A brief description of the synthesis route and production process of fezolinetant

Fezolinetant is a new type of selective neurokinin receptor 3 (NK3) antagonist, mainly used to treat symptoms such as menopausal hot flashes. Optimization of its synthesis route and production process is crucial to ensuring the quality and yield of drugs. The following is a brief introduction to the synthetic route and production process of filazonatant.

The synthesis of nonazonatant usually starts with the construction of the core heterocyclic structure. Through organic synthesis methods, appropriate amino compounds are reacted with aromatic or heterocyclic substrates to form the key heterocyclic skeleton. This step requires strict control of reaction conditions to ensure the selectivity and purity of the product and lay the foundation for subsequent synthesis.

Synthetic intermediates undergo multi-step introduction and modification of functional groups, including oxidation, reduction, substitution and other reactions, to gradually form the complex structure of the target molecule. The key at this stage is to control the stereoselectivity and regioselectivity of the reaction to avoid the generation of undesirable isomers and ensure the activity and safety of the final product.

Finally, after completing the main structure, high-purity nonazonatant API is obtained through processes such as purification, crystallization, and drying. During the production process, process optimization also includes solvent recovery, waste treatment and environmental protection to ensure the economy and environmental protection of the production process.

In general, the synthetic route of nonazonatant involves multiple steps of delicate organic synthesis reactions and strict process control. With the development of technology, the production process has been continuously improved, improving product quality and production efficiency, providing a strong guarantee for clinical application.

Reference materials:https://www.drugs.com/